![]() |
|||||||||||||
|
All | Since 2019 | |
Citation | 5450 | 3969 |
h-index | 23 | 20 |
i10-index | 134 | 84 |
VALIDATED UPLC/Q-TOF-MS METHOD FOR SIMULTANEOUS DETERMINATION OF ANTI-HYPERTENSIVE AND DIURETIC DRUGS IN HUMAN PLASMA AND ITS APPLICATION TO PHARMACOKINETIC STUDY
Hamid Khan*
ABSTRACT In the presented work the ultra-performance liquid chromatographic/quadrupole time-of-flight mass spectrometric (UPLC/Q-TOF-MS) method has been developed for simultaneous determination of telmisartan, hydrochlorothiazide and its major metabolite chlorothiazide in human plasma. For identification of drugs, the Q-TOF mass spectrometer was operated in negative ionization mode and quantification was done using the MS/MS transitions at m/z 513.18 to 469.13 for telmisartan, 295.80 to 204.94 for hydrochlorothiazide and 268.80 to 169.98 for chlorothiazide. The chromatographic separation was achieved on Acquity UPLCTM BEH C18 (100.0 × 2.1 mm, 1.7μm) column using isocratic mobile phase consisting of acetonitrile-2mM ammonium acetate (50:50, v/v) at a flow rate of 0.25 mL/min. The elution of telmisartan, hydrochlorothiazide and chlorothiazide was occurred at 2.25, 1.22, 1.50 min, respectively. The calibration curves were linear over the concentration range of 1-1000 ng/mL for all the compounds. The developed method was validated according to ICH guidelines. The method was applied for pharmacokinetic study of telmisartan and hydrochlorothiazide in human plasma. Keywords: UPLC/Q-TOF-MS, Telmisartan, Hydrochlorothiazide, Chlorothiazide, Pharmacokinetic Study. [Download Article] [Download Certifiate] |